MAFA
BIIB icon

MJT & Associates Financial Advisory’s Biogen BIIB Stock Holding History

MJT & Associates Financial Advisory’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.39K Hold
15
– – ﹤0.01% 309
2026
Q2 		$3.24K Buy
+15
New +$2.87K ﹤0.01% 335

Other funds holding BIIB

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TF
Tompkins Financial Ithaca, New York $1.42B AUM 19.14% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

MJT & Associates Financial Advisory's BIIB Position: Q3 2026 in Review

MJT & Associates Financial Advisory held its Biogen (BIIB) position steady in Q3 2026 at 15 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #309.

MJT & Associates Financial Advisory first reported a position in BIIB in Q2 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • MJT & Associates Financial Advisory held 15 shares of Biogen worth $3.39K as of Q3 2026.
  • MJT & Associates Financial Advisory left its Biogen share count unchanged in Q3 2026.
  • Biogen made up ﹤0.01% of MJT & Associates Financial Advisory's portfolio in Q3 2026, its #309 holding.
  • MJT & Associates Financial Advisory first reported a position in Biogen in Q2 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.